Inhibition of serine hydrolase monoacylglycerol lipase (MAGL) and transcription factor SATB2 could reduce tumor burden of colorectal cancer and was correlated with the downregulation of fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF) [55, 56]. This evidence concerns the gene VEGFA and neoplasm.